Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T29999 | Target Info | |||
Target Name | Vasopressin V1 receptor (V1R) | ||||
Synonyms |
Vasopressin receptor 1; ADH V1 receptor
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | NO-GeName | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Vasopressin V2 receptor (V2R) | Successful Target | ||||
UniProt ID | V2R_HUMAN | |||||
Gene Name | AVPR2 | |||||
Synonyms |
Renal-type arginine vasopressin receptor; DIR3; DIR; Antidiuretic hormone receptor; AVPR V2; ADHR
Click to Show/Hide
|
|||||
Representative Drug(s) | Mozavaptan | Drug Info | Ki = 9.42 nM | [1] | ||
Co-Target Name | Aldehyde oxidase (AOX1) | Successful Target | ||||
UniProt ID | AOXA_HUMAN | |||||
Gene Name | AOX1 | |||||
Synonyms |
AOX1
Click to Show/Hide
|
|||||
Representative Drug(s) | Menadione | Drug Info | IC50 = 200 nM | [2] | ||
Co-Target Name | Indoleamine 2,3-dioxygenase 1 (IDO1) | Successful Target | ||||
UniProt ID | I23O1_HUMAN | |||||
Gene Name | IDO1 | |||||
Synonyms |
Indoleamine-pyrrole 2,3-dioxygenase; INDO; IDO-1; IDO
Click to Show/Hide
|
|||||
Representative Drug(s) | Menadione | Drug Info | IC50 = 370 nM | [3] | ||
Co-Target Name | Monoamine oxidase type B (MAO-B) | Successful Target | ||||
UniProt ID | AOFB_HUMAN | |||||
Gene Name | MAOB | |||||
Synonyms |
MAO-B; Amine oxidase [flavin-containing] B
Click to Show/Hide
|
|||||
Representative Drug(s) | Menadione | Drug Info | Ki = 400 nM | [4] | ||
Co-Target Name | Oxytocin receptor (OTR) | Successful Target | ||||
UniProt ID | OXYR_HUMAN | |||||
Gene Name | OXTR | |||||
Synonyms |
OT-R
Click to Show/Hide
|
|||||
Representative Drug(s) | Mozavaptan | Drug Info | Ki = 660 nM | [5] | ||
Co-Target Name | Thiosulfate sulfurtransferase (TST) | Co-Target | ||||
UniProt ID | THTR_HUMAN | |||||
Gene Name | TST | |||||
Synonyms |
Rhodanese
Click to Show/Hide
|
|||||
Representative Drug(s) | Menadione | Drug Info | IC50 = 1000 nM | [6] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Novel design of nonpeptide AVP V(2) receptor agonists: structural requirements for an agonist having 1-(4-aminobenzoyl)-2,3,4, 5-tetrahydro-1H-1-benzazepine as a template. J Med Chem. 2000 Nov 16;43(23):4388-97. | ||||
REF 2 | Aldehyde oxidase: an enzyme of emerging importance in drug discovery. J Med Chem. 2010 Dec 23;53(24):8441-60. | ||||
REF 3 | Polyketides and Anthranilic Acid Possessing 6-Deoxy-alpha-l-talopyranose from a Streptomyces Species. J Nat Prod. 2017 May 26;80(5):1378-86. | ||||
REF 4 | Molecular insights into human monoamine oxidase (MAO) inhibition by 1,4-naphthoquinone: evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO. Bioorg Med Chem. 2011 Dec 15;19(24):7416-24. | ||||
REF 5 | Selective fluorescent nonpeptidic antagonists for vasopressin V? GPCR: application to ligand screening and oligomerization assays. J Med Chem. 2012 Oct 25;55(20):8588-602. | ||||
REF 6 | HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules. Bioorg Med Chem Lett. 2019 May 1;29(9):1106-1112. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.